Summary
- Profile Type
- Business request
- POD Reference
- BRIT20250225010
- Term of Validity
- 25 February 2025 - 25 February 2026
- Company's Country
- Italy
- Type of partnership
- Supplier agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The italian start-up is specialized in AI-driven metabolic analysis. Their DMA® technology enables non-invasive, AI-powered screening for early diagnosis and personalized treatment. By detecting metabolic patterns, it enhances preventive care, chronic disease management and sports performance. The company seeks suppliers to integrate their cutting-edge solutions into healthcare, thanks to the production of branded biomarker kits.
- Full Description
-
THE TECHNOLOGY
DMA® is based on the detection and analysis of spontaneous electrical currents naturally emitted by the human body, which reflect bioelectrical activity and provide valuable insights into metabolic states. Using a highly sensitive detection system capable of measuring ultra-low electrical emissions in the nanoAmpere range, the sme has identified 61 key reference points across the body, mapped to assess 30 brain regions and multiple organs. This allows for a comprehensive evaluation of metabolic processes and their impact on overall health. The assessment process involves measuring baseline electrical activity at these reference points and then observing variations following indirect exposure to specific biomarkers. These biomarkers, which include biomolecules essential to physiological balance, allow us to pinpoint metabolic deficiencies, increased metabolic demands and potential pathological processes. For instance, DMA® can detect imbalances in amino acids and trace elements, identify metabolic stress markers such as Myc and Ras proteins in tumors or assess neurodegenerative conditions by analyzing phosphorylated Tau protein levels in Alzheimer's disease. Additionally, the system is capable of identifying bacterial, viral and parasitic infections based on the distinct bioelectrical changes these conditions induce in specific body regions. Currently, they have a list of more than 1,500 biomarkers, continuously evolving with the latest scientific discoveries, enabling them to investigate a wide range of biochemical processes impacting our health.
THE ROLE OF BIOMARKERS
Biomarkers are at the core of their research and technological advancement. They enable them to explore and understand a wide range of biochemical processes influencing health and disease. Their biomarker database is continuously expanding, integrating the latest scientific discoveries to enhance diagnostic precision and metabolic analysis. By refining and updating these biomarkers, they can delve deeper into physiological and pathological metabolic processes, improving their ability to detect and monitor various conditions.
WHAT THEY ARE LOOKING FOR
To further develop its technology and expand its applications, they are seeking collaborators who can supply vials containing their selected biomolecules at homeopathic dilutions, complete with certification. These biomarkers must meet high standards of purity and reliability to ensure the accuracy and effectiveness of their assessments.
COLLABORATION AND PRODUCTION SCALE
Their technology is designed for widespread adoption by healthcare professionals in Italy and globally. As a result, the production of branded biomarker kits is expected to grow significantly over time. They are looking for partners who can support large-scale production while maintaining stringent quality control standards. By joining forces, they aim to enhance metabolic diagnostics and pioneer new frontiers in personalized healthcare. - Advantages and Innovations
-
● Revolutionary Non-Invasive Technology – DMA® provides a painless, real-time metabolic
assessment, eliminating the need for invasive procedures such as biopsies or blood tests.
● Early Disease Detection – By identifying metabolic imbalances before symptoms appear, DMA® enables proactive interventions, improving patient outcomes and advancing preventive medicine.
● Comprehensive and Multi-System Analysis – The technology can evaluate metabolic activity across 30 brain regions and multiple organs, offering an unprecedented level of diagnostic depth.
● AI-Powered Precision – Advanced machine learning algorithms enhance diagnostic accuracy, ensuring precise identification of metabolic markers while minimizing false positives and negatives.
● Expansive Biomarker Library – With over 1,500 biomarkers and continuous updates based on scientific discoveries, DMA® provides a robust framework for assessing a wide spectrum of health conditions.
● Personalized Treatment Optimization – By monitoring real-time metabolic responses, DMA® enables tailored therapeutic strategies, optimizing treatments for chronic diseases like diabetes, cardiovascular disorders and autoimmune conditions.
● Rapid and Cost-Effective Assessments – The efficiency of DMA® reduces diagnostic timelines and healthcare costs, improving accessibility and resource allocation in clinical settings.
● Scalable and Future-Ready – The flexibility of our platform ensures seamless integration with evolving healthcare technologies, solidifying DMA® as a cornerstone of the future of precision medicine. - Technical Specification or Expertise Sought
- The sme seeks a partner with expertise in the preparation and certification of biological molecules in homeopathic dilutions, specifically CH4, D6 and D8, in hydroalcoholic solutions. The ideal collaborator will have experience in handling proteins, amino acids and other biomolecules, ensuring their stability and effectiveness in solution. Additionally, the ability to conduct rigorous quality control processes and provide certification of the vial contents is essential to meet regulatory and operational requirements. The partner should also be able to manage large-scale production, guaranteeing consistent quality across batches. Expertise in sterile production environments and adherence to international standards for medical and diagnostic supplies are highly desirable. The ability to develop scalable production workflows will be crucial as demand for our biomarker kits continues to grow in both national and international healthcare markets.
- Stage of Development
- Available for demonstration
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 10: Reduced Inequality
- Goal 9: Industry, Innovation and Infrastructure
- IPR status
- IPR applied but not yet granted
Partner Sought
- Expected Role of a Partner
- The sme is looking for a company or startup specializing in the dilution of biological molecules, including proteins and amino acids, into homeopathic dilutions (CH4, D6, D8) in hydroalcoholic solutions. The partner must be capable of ensuring the precise preparation and certification of these solutions, verifying the composition of each vial produced. The vials should be made of glass or plastic, hermetically sealed to ensure stability and sterility. Additionally, they seek a partner who can provide labeling solutions, allowing them to include both the molecule name and the startup's brand identity on each vial. Since their technology will be adopted by healthcare professionals in Italy and worldwide, production must be scalable to meet increasing market demand. The ability to support large-scale manufacturing and distribution, while maintaining the highest quality standards, will be a key factor in selecting the right collaborator. This partnership will be instrumental in expanding the impact of their metabolic diagnostic solutions and bringing their innovative healthcare technology to a global audience.
- Type and Size of Partner
- SME 11-49
- Big company
- SME 50 - 249
- SME <=10
- Type of partnership
- Supplier agreement
Dissemination
- Technology keywords
- 09003 - Electronic measurement systems
- 06005002 - Sensors & Wireless products
- 01003003 - Artificial Intelligence (AI)
- 06005003 - Health information management
- 01004001 - Applications for Health
- Market keywords
- 05003001 - Therapeutic services
- 05004005 - Diagnostic equipment
- 05004001 - Electromedical and medical equipment
- 05001001 - Diagnostic services
- 05007004 - Monitoring equipment
- Targeted countries
- All countries
